NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection.
about
Hydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoterA platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cellsThalidomide inhibits the replication of human immunodeficiency virus type 1TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virusModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsDoes HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. European Society for Clinical Investigation.Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA constructIntravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis.The natural history and antiviral treatment of hepatitis C in haemophilia.Viruses, chemotherapy and immunity.Lymphocyte subset diversity in idiopathic CD4+ T lymphocytopenia.Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis.The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease ControlEvaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndromeHIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.Antiviral therapy: current concepts and practicesEnhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDSTurnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infectionTropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countriesAssociation of HIV-Induced Immunosuppression and Clinical Malaria in Nigerian Adults.Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latencyProlonged replication in the mouse central nervous system of reoviruses isolated from persistently infected cell cultures.Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes.Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.AIDS-associated lymphomas and other cancers in individuals with haemophilia.Increased frequency of detection of Ureaplasma urealyticum and Mycoplasma genitalium in AIDS patients without urethral symptoms.Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals.
P2860
Q28344235-A510DD5E-A19E-4748-875A-C8F358EA6EB3Q28368010-FF3C1F3F-A84E-46BB-8E40-D4338863E1DDQ28378516-3E493EFE-D1EA-4355-903D-E906070C2DDAQ28379433-BE0BD498-A816-447B-B182-01FB51106DB3Q28551803-98AD87FD-BBAF-4316-BF2B-5C5569BA74CEQ33547798-C7465028-427B-4D3B-AAD2-CDB835C64A7FQ33591573-7BB42B31-80CE-4B87-B9FC-8335DDC44699Q33717470-5DFB48AF-65B4-4953-9004-208DFD297F0CQ33822538-29A7ACD5-ACA4-4607-8561-708E13EF4D69Q33890774-DAC24593-10C0-4076-A17C-B1AD6CA9F023Q34045678-E92A4098-F861-4D3E-A4BE-37B01403443DQ34227778-12EE2515-0E23-40B0-910B-0CFF479DDBC4Q34524452-6AC85C36-341A-4165-83BD-341E6B755DEEQ34637021-D4F2FA15-CC97-4C95-A7BA-4E3A12506376Q35172760-B65EB6F9-84FE-4D29-BAC2-6DD7E576CEF6Q35227906-8DFE3270-3800-4F37-8DDC-28CBC5A8FD43Q35369891-7F470B42-C911-4ECA-87BA-0FCDF5DEC322Q35452693-D639B146-A3D8-442C-A24D-0CE69BD16DC3Q35519550-E701ABC3-F08D-4EFE-9DEC-A278F7378DECQ35531651-5A93AD4F-1C8A-4C45-A65F-976E16ECE25EQ35844702-4564D8D8-7748-4789-9D5E-FB226C137E50Q35909944-FA08F422-3DDC-4551-8AFC-42B46DDCBDE0Q35951983-6665A24F-0C47-435E-BD52-E17252323B79Q35970108-BF18AB20-983D-4BD0-91AC-F7EAE6E2FD51Q36070394-5101CDB5-6E9F-482D-B750-9871A477613AQ36361692-13F7A77D-8F07-43C4-8B89-5C72F75EBC05Q36400220-5BCCE58F-BEBB-447B-8BF4-62080731FE0AQ36400677-B37ED28B-8B66-4B2F-8E0C-CF76FF9EB0DFQ36410953-3F51FA20-A073-4895-8E28-0290603515AEQ36566506-B8100362-906F-4F04-9943-2C50BCCA4EE7Q36627614-F385883B-2EE0-4B68-A5E5-55B1E28A16E1Q36632804-4957D570-AA82-4ABF-81FF-6096493429A4Q36646773-0FB856D7-D4C3-43BD-9F58-A0E4E8A29929Q36685254-7108E56F-C2D6-4F5E-B8F4-57FA2EB0FFE2Q37116239-1335B4D0-F71D-4A5C-ACEA-1B7D0DB18698Q37292229-2C70A0C6-FAAB-442A-A751-065A965509C5Q37365773-B8A9A721-C2A9-42EE-955F-76353AA28B61Q38841818-5C50135E-47FA-4CA7-BBAA-D68508B3D659Q39449881-14334896-40C3-4F6B-8086-AECD0F9CB253Q39869805-B04F6644-E51A-40F0-A239-3A80AC3B9080
P2860
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@ast
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@en
type
label
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@ast
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@en
prefLabel
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@ast
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@en
P2093
P1476
NIH conference. Immunopathogen ...... iciency virus (HIV) infection.
@en
P2093
P304
P356
10.7326/0003-4819-114-8-678
P407
P577
1991-04-01T00:00:00Z